IFG Advisory LLC Lowers Position in iShares Biotechnology ETF $IBB

IFG Advisory LLC lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 27.5% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 2,985 shares of the financial services provider’s stock after selling 1,130 shares during the quarter. IFG Advisory LLC’s holdings in iShares Biotechnology ETF were worth $378,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Arkadios Wealth Advisors lifted its holdings in iShares Biotechnology ETF by 13.6% in the 2nd quarter. Arkadios Wealth Advisors now owns 6,917 shares of the financial services provider’s stock valued at $875,000 after purchasing an additional 828 shares in the last quarter. World Investment Advisors lifted its holdings in iShares Biotechnology ETF by 10.4% in the 2nd quarter. World Investment Advisors now owns 7,684 shares of the financial services provider’s stock valued at $972,000 after purchasing an additional 721 shares in the last quarter. Quaker Wealth Management LLC raised its holdings in shares of iShares Biotechnology ETF by 200.0% during the 2nd quarter. Quaker Wealth Management LLC now owns 969 shares of the financial services provider’s stock worth $123,000 after acquiring an additional 1,938 shares during the period. Ashton Thomas Private Wealth LLC raised its holdings in shares of iShares Biotechnology ETF by 769.9% during the 2nd quarter. Ashton Thomas Private Wealth LLC now owns 63,691 shares of the financial services provider’s stock worth $8,058,000 after acquiring an additional 56,369 shares during the period. Finally, Envestnet Asset Management Inc. raised its holdings in shares of iShares Biotechnology ETF by 5.8% during the 2nd quarter. Envestnet Asset Management Inc. now owns 56,079 shares of the financial services provider’s stock worth $7,095,000 after acquiring an additional 3,051 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 1.2%

NASDAQ IBB opened at $157.46 on Tuesday. The business’s fifty day simple moving average is $147.19 and its 200-day simple moving average is $134.68. iShares Biotechnology ETF has a 52 week low of $107.43 and a 52 week high of $159.79.

iShares Biotechnology ETF Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were given a dividend of $0.0828 per share. This represents a $0.33 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend was Tuesday, September 16th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.